发明名称 Compounds useful for treatment or prevention of disease mediated by alpha-2B-adrenoceptor
摘要 Disclosed are compounds of formula (I) or a pharmaceutically acceptable salt thereof wherein R1, R2, R3, R4 and R5 are independently selected from the list consisting of H, a straight or branched alkyl or alkoxy group with 1 to 4 carbon atoms, or a halogen; X is H, a straight or branched alkyl group with 1 to 4 carbon atoms, phenyl or -OH; Z is H, acetyl, -CH2-Ph-O-CF3 or CH2-Ph-CF3; Y is a ring structure linked to formula (I) directly or with an alkyl chain having one or two carbon atoms. Further disclosed is the use of said compounds for the manufacture of a pharmaceutical preparation useful for the treatment or prevention of a disease mediated by the alpha-2B-adrenoceptor in a mammal. The pharmaceutical preparation containing this compound may be useful in treating a coronary heart disease, acute myocardial infarction, unstable angina pectoris, Prinzmetal's variant form of angina pectoris, other forms of chronic angina pectoris, essential hypertension, restenosis after coronary angioplasty or a vascular disease such as: vasoconstriction subsequent to subachnoid haemorrhage, hypoxic brain damage subsequent to subarachnoid haemorrhage, migraine, Raynaud's disease, cold intolerance, pre-eclampsia, male erectile dysfunction or obesity.
申请公布号 NZ530366(A) 申请公布日期 2005.02.25
申请号 NZ20020530366 申请日期 2002.07.22
申请人 OY JUVANTIA PHARMA LIMITED 发明人 JOUTSAMO, TOPI;TAUBER, ANDREI YURIEVITCH;SALO, HARRI;HOFFREN, ANNA-MARJA;WURSTER, SIEGFRIED
分类号 C07D239/69;A61K31/635;A61K45/00;A61P3/04;A61P9/10;A61P9/12;A61P15/00;A61P15/10;A61P25/02;A61P25/06;A61P43/00;C07D239/42;C07D401/12;C07D403/12;(IPC1-7):C07D239/69;A61K31/495;A61P9/00 主分类号 C07D239/69
代理机构 代理人
主权项
地址